14:52:22 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-21 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-07-02 Extra Bolagsstämma 2024
2024-05-23 Kvartalsrapport 2024-Q1
2024-03-22 X-dag ordinarie utdelning CURAS 0.00 DKK
2024-03-21 Årsstämma 2024
2024-02-22 Bokslutskommuniké 2023
2023-11-23 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-25 Kvartalsrapport 2023-Q1
2023-03-31 X-dag ordinarie utdelning CURAS 0.00 DKK
2023-03-30 Årsstämma 2023
2023-02-23 Bokslutskommuniké 2022
2022-11-24 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-24 Kvartalsrapport 2022-Q1
2022-04-27 Årsstämma 2022
2022-03-25 X-dag ordinarie utdelning CURAS 0.00 DKK
2022-02-24 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-24 Kvartalsrapport 2021-Q2
2021-06-01 Extra Bolagsstämma 2021
2021-05-20 Kvartalsrapport 2021-Q1
2021-03-26 X-dag ordinarie utdelning CURAS 0.00 DKK
2021-03-25 Årsstämma 2021
2021-02-24 Bokslutskommuniké 2020
2020-11-30 Kvartalsrapport 2020-Q3

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriMedicinteknik
Curasight är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom utveckling av teknologiska produkter. Produktportföljen är bred och har sin huvudsakliga fokus på utveckling av produkter inom området Positron Emissions Tomography (PET). Verksamheten drivs med störst närvaro inom Skandinavien. Curasight har sitt huvudkontor i Köpenhamn.
2024-07-02 14:11:38

Copenhagen, Denmark, 2 July 2024 - today Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) held an Extraordinary General Meeting at the office of DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen OE, Denmark

Today, the shareholders in Curasight passed the following resolutions at an Extraordinary General Meeting in accordance with the agenda:

1. Proposals from the Board of Directors

1.1 Authorisation to the Board of Directors to issue warrants with pre-emption   rights

A proposal from the Board of Directors to introduce a warrant authorization to the Board of Directors in the Company's Articles of Association was unanimously adopted with all votes represented at the general meeting. Consequently, the Company's Articles of Association will be updated to incorporate the following new sections:

5.2.3 Selskabets bestyrelse The Company's board of directors is
er bemyndiget til ad authorised, pursuant to s. 155 of the Danish
én eller flere gange i Companies Act, cf. s. 169 thereof, in one or
henhold til several instances, to issue up to a total of
selskabslovens § 155, 4,000,000 warrants in the Company, which will
jf. § 169, at udstede entitle their holder(s) to subscribe for up
op til 4.000.000 to a total of nominally DKK 200,000 shares in
warrants i Selskabet the Company with pre-emption rights for the
med ret til tegning af existing shareholders at a subscription price
op til i alt nominelt and allocation determined by the board of
200.000 kr. directors. The subscription price may be
kapitalandele i below the market price at the time of the
Selskabet med decision of the board of directors.
fortegningsret for de
eksisterende
kapitalejere til en
kurs og fordeling, som
fastlægges af
bestyrelsen. Kursen
kan være under
markedskursen på
tidspunktet for
bestyrelsens
beslutning.
Samtidig er The Company's board of directors is also
bestyrelsen bemyndiget authorised to carry out any related share
til at foretage den capital increases, in one or several
dertil hørende instances, up to a total of nominally DKK
forhøjelse af 200,000 or such other amount as required
Selskabets following an adjustment of the number of
aktiekapital ad en warrants, the numbers of shares that issued
eller flere omgange warrants entitle the holder(s) to subscribe
med op til nominelt and/or the exercise price in accordance with
200.000 kr. eller et the terms governing the issued warrants. The
andet beløb som følge authorization is valid until 2 July 2029.
af eventuel regulering Shares issued pursuant to the authorization
af antallet af in this clause 5.2.3 must be paid up in full
udstedte warrants, by conversion of debt or by cash payment, be
antallet af negotiable instruments, be registered by name
kapitalandele, som de and be registered by the name of shareholders
udstedte warrants in the Company's shareholders' register. The
giver ret til at same restrictions on transferability as those
tegne, og/eller applying to the existing shares apply and no
tegningskursen i shareholder shall be obligated to have the
henhold til de til shares redeemed partly or in full.
enhver tid gældende
vilkår for de udstedte
warrants.Bemyndigelsen
løber frem til 2. juli
2029. Aktier udstedt i
henhold til
bemyndigelsen i dette
pkt. 5.2.3 skal
indbetales fuldt ud
ved gældskonvertering
eller kontant indskud,
være
omsætningspapirer,
skal lyde på navn og
noteres på navn i
Selskabets ejerbog.
Der gælder samme
indskrænkninger i
aktiernes
omsættelighed, som
gælder for de
eksisterende aktier,
og ingen aktionær er
forpligtet til at lade
aktier indløse helt
eller delvist.
Bestyrelsen er The board of directors is authorized to reuse
bemyndiget til at or reissue any lapsed, non-exercised
genanvende eller warrants, provided that such reuse or
genudstede eventuelle reissuance observes the terms and the
bortfaldne ikke expiration date set out in this
-udnyttede warrants, authorization.
forudsat at
genanvendelsen eller
genudstedelsen finder
sted inden for de
vilkår og tidsmæssige
begrænsninger, der
fremgår af
bemyndigelsen.

1.2 Authorisation to the Board of Directors to issue warrants without pre-emption rights

A proposal from the Board of Directors to introduce a warrant authorization to the Board of Directors in the Company's Articles of Association was unanimously adopted with all votes represented at the general meeting. Consequently, the Company's Articles of Association will be updated to incorporate the following new sections:

5.2.4 Selskabets bestyrelse The Company's board of directors is
er bemyndiget til ad authorised, pursuant to s. 155 of the Danish
én eller flere gange i Companies Act, cf. s. 169 thereof, in one or
henhold til several instances, to issue up to a total of
selskabslovens § 155,  4,000,000 warrants in the Company, which
jf. § 169, at udstede will entitle their holder(s) to subscribe for
op til 4.000.000  up to a total of nominally DKK 200,000 shares
warrants i Selskabet in the Company without pre-emption rights for
med ret til tegning af the existing shareholders at a subscription
op til i alt nominelt price and allocation determined by the board
200.000 kr. of directors. The subscription price may be
kapitalandele i below the market price at the time of the
Selskabet uden decision of the board of directors.
fortegningsret for de
eksisterende
kapitalejere i
Selskabet til en kurs
og fordeling, som
fastlægges af
bestyrelsen. Kursen
kan være under
markedskursen på
tidspunktet for
bestyrelsens
beslutning.
Samtidig er The Company's board of directors is also
bestyrelsen bemyndiget authorised to carry out any related share
til at foretage den capital increases, in one or several
dertil hørende instances, up to a total of nominally DKK
forhøjelse af 200,000 or such other amount as required
Selskabets following an adjustment of the number of
aktiekapital ad en warrants, the numbers of shares that issued
eller flere omgange warrants entitle the holder(s) to subscribe
med op til nominelt and/or the exercise price in accordance with
200.000 kr. eller et the terms governing the issued warrants. The
andet beløb som følge authorization is valid until 2 July 2029.
af eventuel regulering Shares issued pursuant to the authorization
af antallet af in this clause 5.2.4 must be paid up in full
udstedte warrants, by conversion of debt or by cash payment, be
antallet af negotiable instruments, be registered by name
kapitalandele, som de and be registered by the name of shareholders
udstedte warrants in the Company's shareholders' register. The
giver ret til at same restrictions on transferability as those
tegne, og/eller applying to the existing shares apply and no
tegningskursen i shareholder shall be obligated to have the
henhold til de til shares redeemed partly or in full.
enhver tid gældende
vilkår for de udstedte
warrants.Bemyndigelsen
løber frem til 2. juli
2029. Aktier udstedt i
henhold til
bemyndigelsen i dette
pkt. 5.2.4 skal
indbetales fuldt ud
ved gældskonvertering
eller kontant indskud,
være
omsætningspapirer,
skal lyde på navn og
noteres på navn i
Selskabets ejerbog.
Der gælder samme
indskrænkninger i
aktiernes
omsættelighed, som
gælder for de
eksisterende aktier,
og ingen aktionær er
forpligtet til at lade
aktier indløse helt
eller delvist.
Bestyrelsen er The board of directors is authorized to reuse
bemyndiget til at or reissue any lapsed, non-exercised
genanvende eller warrants, provided that such reuse or
genudstede eventuelle reissuance observes the terms and the
bortfaldne ikke expiration date set out in this
-udnyttede warrants, authorization.
forudsat at
genanvendelsen eller
genudstedelsen finder
sted inden for de
vilkår og tidsmæssige
begrænsninger, der
fremgår af
bemyndigelsen.

1.3 Authorisation to the chairman of the meeting

The general meeting adopted a resolution to authorise the chairman of the meeting Ulrik Bangsbo Hansen to apply for registration of the resolutions passed and to make certain amendments, if necessary.

***

The Company's new articles of association will be published on the Company's website once they have been registered with the Danish Business Authority, and likewise, the minutes of the Extraordinary General Meeting will also be made available on the website.